8-K: Nu Skin Enterprises Reports Second Quarter Results, Rhyz Business Shows Strong Growth

Nu Skin Enterprises announced second quarter results in line with revenue guidance, with the Rhyz business growing 32.3% year-over-year, while the core Nu Skin business navigates macroeconomic challenges.

Summary

• Nu Skin Enterprises reported second quarter 2024 revenue of $439.1 million, a 12.2% decrease compared to the prior year, but in line with top-line guidance.
• The company experienced a 4.2% negative impact from foreign exchange rates, equating to a $21.0 million reduction in revenue.
• Rhyz revenue grew significantly by 32.3% to $67.8 million, driven by strong performances in the Mavely affiliate platform and manufacturing companies.
• Earnings per share (EPS) were reported at $(2.38), but excluding restructuring and impairment charges, EPS was $0.21, slightly exceeding projections.
• The company's customer base decreased by 14% to 893,514, and paid affiliates decreased by 17% to 155,486, although this was a 9% decrease excluding an adjustment to eligibility requirements.
• Sales leaders also saw a decrease of 16% to 38,592.
• Nu Skin is intensifying its transformation efforts to become a leading integrated beauty, wellness and lifestyle ecosystem.
• The company is enhancing its developing market strategy, including a revised business model and streamlined operating infrastructure, starting with Latin America and parts of Southeast Asia.
• Plans are underway to enter India with a proprietary business model.
• The company is exploring integrated brand building initiatives, including digital marketing and third-party marketplaces.
• A $141 million non-cash charge was recorded for impairment of goodwill and other intangibles due to a decline in stock price and current market conditions.
• The company generated $51.2 million in cash from operations, reduced inventory levels, and paid down debt.
• Full-year 2024 revenue is now projected to be in the range of $1.73 to $1.81 billion, with earnings of $(2.01) to $(1.81) or $0.75 to $0.95 excluding restructuring and impairment charges.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company met revenue guidance and Rhyz showed strong growth, the overall revenue decline, customer base reduction, and significant impairment charge temper the positive aspects. The narrowing of guidance also suggests some caution.

Positives

• Rhyz business demonstrated strong growth with a 32.3% increase in revenue.
• Adjusted earnings per share slightly exceeded projections.
• The company is actively pursuing cost-saving initiatives and has reduced G&A expenses.
• Nu Skin generated $51.2 million in cash from operations and reduced inventory levels.
• The company is enhancing its developing market strategy and planning to enter India.
• Sequential gains were seen in several markets including the U.S. and most of Southeast Asia/Pacific.

Negatives

• Overall revenue decreased by 12.2% year-over-year.
• The company experienced a 4.2% negative impact from foreign exchange rates.
• Customer base decreased by 14% and paid affiliates decreased by 17%.
• A significant $141 million non-cash impairment charge was recorded.
• Gross margin decreased from 72.9% to 70.0%.
• Operating margin was (28.6)%, or 5.4% excluding restructuring and impairment charges, compared to 8.5% in the prior year.

Risks

• The company faces challenges from macroeconomic conditions impacting the core Nu Skin business.
• Foreign exchange rate fluctuations continue to negatively impact revenue.
• There is a risk of continued decline in customer base and paid affiliates.
• The company is exposed to risks associated with operating in international markets, including regulatory and political uncertainties.
• There are risks related to the success of new initiatives and product launches.
• The company faces competitive pressures in its markets.

Future Outlook

The company expects continued sequential improvement with projected Q3 revenue of $430 to $465 million and earnings per share of $0.08 to $0.18 or $0.15 to $0.25 excluding restructuring and impairment charges. Full-year 2024 revenue is projected to be in the range of $1.73 to $1.81 billion, with earnings of $(2.01) to $(1.81) or $0.75 to $0.95 excluding restructuring and impairment charges.

Management Comments

• We are pleased with our progress as we perform to plan on our transformational efforts, and we are on track as evidenced by our second quarter results, said Ryan Napierski, Nu Skin president and CEO.
• Our revenue was in-line with our expectations despite a 4 percent FX headwind, while adjusted earnings per share slightly exceeded our projections due to heightened operational discipline, excluding our restructuring and impairment charges.
• We remain on track with our cost efficiency program as reflected by our reductions in G&A expense, helping to protect profitability despite revenue pressures, said James D. Thomas, chief financial officer.
• Given that we have performed in-line with expectations for the first half of the year while also considering the increasing FX headwind, we believe it prudent to narrow our annual revenue guidance range.

Industry Context

The direct selling industry is facing challenges due to changing consumer preferences and macroeconomic pressures. Nu Skin's focus on digital transformation and expansion into new markets aligns with industry trends to adapt to these changes. The growth of the Rhyz business indicates a diversification strategy that could provide a competitive advantage.

Comparison to Industry Standards

• Nu Skin's revenue decline of 12.2% is worse than some of its peers in the direct selling industry, which have seen more moderate declines or even growth in certain segments.
• Herbalife, for example, reported a 2.7% decline in net sales in their most recent quarter, indicating a better performance than Nu Skin.
• Amway, another major player, has also been focusing on digital transformation and product innovation, similar to Nu Skin's strategy.
• The 32.3% growth in Rhyz revenue is a positive outlier compared to the overall performance of the direct selling segment, suggesting that Nu Skin's diversification strategy is showing promise.
• The impairment charge of $141 million is significant and reflects the challenges the company is facing in the current market conditions, which is not uncommon in the industry but is a large charge compared to some peers.

Stakeholder Impact

• Shareholders will be impacted by the decrease in revenue and the significant impairment charge, but may be encouraged by the growth in the Rhyz business and the company's transformation efforts.
• Employees may be affected by the cost-saving initiatives and restructuring efforts.
• Customers may see changes in product offerings and the overall business model.
• Affiliates may be impacted by the changes in eligibility requirements and the introduction of the new app.
• Suppliers may be affected by changes in the company's product portfolio and operating infrastructure.

Next Steps

• The company plans to implement changes to eligibility requirements in additional segments over the next several quarters.
• The company will continue to refine its operating model and pursue cost-saving initiatives.
• The company plans to introduce a Nu Skin/Mavely app in the second half of the year in the U.S.
• The company will intensify its plans to enter India with a proprietary business model.
• The company will explore integrated brand building initiatives, including digital marketing and third-party marketplaces.

Key Dates

Keywords

Nu Skin, Rhyz, Direct Selling, Beauty, Wellness, Affiliate Marketing, Financial Results, Revenue, Earnings Per Share, Impairment, Transformation, Emerging Markets, Mavely, Digital Marketing